Protara Therapeutics Inc (NASDAQ:TARA)
| 1.71 Delayed Data As of Sep 22 |  -0.12 / -6.56%Today’s Change | 1.62 Today|||52-Week Range 4.18 | -36.19% Year-to-Date |
Latest TARA News | Press Releases
No recent news for Protara Therapeutics Inc.
Today’s Trading
| Previous close | 1.83 |
| Today’s open | 1.78 |
| Day’s range | 1.71 - 1.78 |
| Volume | 175 |
| Average volume (3 months) | 28,596 |
| Market cap | $19.9M |
Data as of 3:59pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | -39.24% |
| Earnings growth (this year) | +45.97% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.19 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ORGSOrgenesis Inc | +0.05 | +8.80% |
| ZIVOZivo Bioscience Inc | -0.02 | -1.77% |
| BCELAtreca Inc | -0.01 | -2.15% |
| AEZSAeterna Zentaris Inc | -0.11 | -4.21% |
Data as of 3:58pm ET, 09/22/2023
Financials
| Next reporting date | November 2, 2023 |
| EPS forecast (this quarter) | -$0.74 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$66.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
